Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731096 | PMC |
| http://dx.doi.org/10.3389/fimmu.2022.1059011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The development and maintenance of immunity against visceral leishmaniasis.
Front Immunol
January 2025
Centre of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Understanding the development and maintenance of immunological memory is important for efforts to eliminate parasitic diseases like leishmaniasis. Leishmaniasis encompasses a range of pathologies, resulting from infection with protozoan parasites belonging to the subgenera and of the genus A striking feature of these infections is that natural or drug-mediated cure of infection generally confers life-long protection against disease. The generation of protective T cell responses are necessary to control infections.
View Article and Find Full Text PDFImmunological characterization of pleural effusions in pediatric patients.
Front Immunol
December 2024
Department of General Pediatrics and Neonatology, Saarland University, Campus Homburg, Homburg, Germany.
Background: The pleural cavity represents a unique immunological compartment that can mount inflammatory reactions during infections, after surgery and in chronic immunological diseases. The connection between systemic immune reactions in the blood and local immune reactions in pleural effusions remains unclear. This study provides the first comprehensive immunological characterization of paired blood and pleural effusion samples, utilizing combined cell and cytokine analyses in pediatric patients undergoing cardiac surgery.
View Article and Find Full Text PDFE2F1-induced autocrine IL-6 inflammatory loop mediates cancer-immune crosstalk that predicts T cell phenotype switching and therapeutic responsiveness.
Front Immunol
November 2024
Institute of Experimental Gene Therapy and Cancer Research, Rostock University Medical Center, Rostock, Germany.
Melanoma is a metastatic, drug-refractory cancer with the ability to evade immunosurveillance. Cancer immune evasion involves interaction between tumor intrinsic properties and the microenvironment. The transcription factor E2F1 is a key driver of tumor evolution and metastasis.
View Article and Find Full Text PDFImmunomodulatory effects of cysteamine and its potential use as a host-directed therapy for tuberculosis.
Front Immunol
November 2024
Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani-Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy.
Objective: Cysteamine, a drug approved to treat cystinosis, has been proposed as a host-directed therapy for (Mtb) and SARS-CoV-2. The impact of cysteamine on the immune responses has not been fully investigated. We aimed to evaluate the immunomodulatory effects of cysteamine on peripheral blood mononuclear cells (PBMCs) using the purified protein derivative (PPD) as a recall antigen, and an unspecific stimulus as staphylococcal enterotoxin B (SEB).
View Article and Find Full Text PDFCase study: May human norovirus infection be associated with premature delivery?
Virol Sin
December 2024
Department of Microbiology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China. Electronic address:
Article Synopsis
- Human norovirus (HuNoV) is a major cause of gastroenteritis and poses additional risks for pregnant women, especially those with immune deficiencies.
- A recent study examined four pregnant women infected with HuNoV who experienced premature rupture of membranes, indicating potential complications.
- Findings revealed significant pathological changes in the fetal membranes and placenta, suggesting a possible link between HuNoV infection and adverse pregnancy outcomes, warranting further clinical attention.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!